Mesoblast Ltd has released a press release.
Information For Retail Shareholders
Filed with ASX ·
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Mesoblast
- Mesoblast Completes Institutional Allocation
- Entitlement Offer and Placement Investor Presentation
- MSB Launches Entitlement Offer and Placement
- Update on BLA for Graft Versus Host Disease
- MSB Reports Q3 Financial Results and Operational Highlights
Later from Mesoblast
- FDA Grants Rare Pediatric Disease Designation for Revascor
- FDA Grants Orphan Drug Designation for Revascor
- Half Year Financial Results Presentation
- MSB Q2 Financial Results and Operational Highlights
- FDA Supports Accelerated Approval Pathway for Heart Failure
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast